Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography.

Autor:	Pandian NG; Hoag Hospital, Newport Beach, California. Electronic address: ase@asecho.org., Kim JK; University of California, Irvine, Irvine, California., Arias-Godinez JA; Instituto Nacional de Cardiología Ignacio Chavez, Mexico City, Mexico., Marx GR; Boston Children's Hospital, Boston, Massachusetts., Michelena HI; Mayo Clinic, Rochester, Minnesota., Chander Mohan J; Fortis Hospital, New Delhi, India., Ogunyankin KO; First Cardiology Consultants Hospital, Lagos, Nigeria., Ronderos RE; Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina., Sade LE; Baskent University, Ankara, Turkey., Sadeghpour A; MedStar Health Research Institute, Washington, District of Columbia., Sengupta SP; Sengupta Hospital and Research Institute, Nagpur, India., Siegel RJ; Cedars-Sinai Medical Center, Los Angeles, California., Shu X; Fudan University, Shanghai, China., Soesanto AM; Universitas Indonesia/National Cardiovascular Center Harapan Kita, Jakarta, Indonesia., Sugeng L; North Shore University Hospital, Manhasset, New York., Venkateshvaran A; Karolinska Institutet, Stockholm, Sweden., Campos Vieira ML; Sao Paulo University Medical School, São Paulo, Brazil., Little SH; Houston Methodist Hospital, Houston, Texas.
Jazyk:	angličtina
Zdroj:	Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography [J Am Soc Echocardiogr] 2023 Jan; Vol. 36 (1), pp. 3-28. Date of Electronic Publication: 2022 Nov 23.
DOI:	10.1016/j.echo.2022.10.009
Abstrakt:	Acute rheumatic fever and its chronic sequela, rheumatic heart disease (RHD), pose major health problems globally, and remain the most common cardiovascular disease in children and young people worldwide. Echocardiography is the most important diagnostic tool in recognizing this preventable and treatable disease and plays an invaluable role in detecting the presence of subclinical disease needing prompt therapy or follow-up assessment. This document provides recommendations for the comprehensive use of echocardiography in the diagnosis and therapeutic intervention of RHD. Echocardiographic diagnosis of RHD is made when typical findings of valvular and subvalvular abnormalities are seen, including commissural fusion, leaflet thickening, and restricted leaflet mobility, with varying degrees of calcification. The mitral valve is predominantly affected, most often leading to mitral stenosis. Mixed valve disease and associated cardiopulmonary pathology are common. The severity of valvular lesions and hemodynamic effects on the cardiac chambers and pulmonary artery pressures should be rigorously examined. It is essential to take advantage of all available modalities of echocardiography to obtain accurate anatomic and hemodynamic details of the affected valve lesion(s) for diagnostic and strategic pre-treatment planning. Intraprocedural echocardiographic guidance is critical during catheter-based or surgical treatment of RHD, as is echocardiographic surveillance for post-intervention complications or disease progression. The role of echocardiography is indispensable in the entire spectrum of RHD management. (Copyright © 2022. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu